🇺🇸 HEXAMINOLEVULINATE in United States

13 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Arthritis Reactive — 2 reports (15.38%)
  2. Cystitis Noninfective — 2 reports (15.38%)
  3. Post Procedural Complication — 2 reports (15.38%)
  4. Agitation — 1 report (7.69%)
  5. Anaphylactic Shock — 1 report (7.69%)
  6. Angina Pectoris — 1 report (7.69%)
  7. Arthralgia — 1 report (7.69%)
  8. Blood Pressure Decreased — 1 report (7.69%)
  9. Blood Urine Present — 1 report (7.69%)
  10. Conjunctival Hyperaemia — 1 report (7.69%)

Source database →

HEXAMINOLEVULINATE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is HEXAMINOLEVULINATE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for HEXAMINOLEVULINATE in United States?

Marketing authorisation holder not available in our data.